|
1
|
Siegel RL, Miller KD, Fedawa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hyodo I, Suzuki H, Takahashi K, Saito Y,
Tanaka S, Chiu HM, Kim NK, Li J, Lim R, Villalon A and Boku N:
Present status and perspectives of colorectal cancer in Asia:
Colorectal cancer working Group report in 30th Asia-Pacific Cancer
Conference. Jpn J Clin Oncol. 40 (Suppl 1):i38–i43. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sung JJ, Lau JY, Young GP, Sano Y, Chiu
HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R, et al: Asia
Pacific consensus recommendations for colorectal cancer screening.
Gut. 57:1166–1176. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D and Weinberg RA: Hallmarks of
Cancer: The Next Generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thomas J, Ohtsuka M, Pichler M and Ling H:
MicroRNAs: Clinical relevance in colorectal cancer. Int J Mol Sci.
16:28063–28076. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong YJ, Yu J and Ng SS: MicroRNA
dysregulation as a prognostic biomarker in colorectal cancer.
Cancer Manag Res. 6:405–422. 2014.PubMed/NCBI
|
|
12
|
Giles KM, Brown RA, Epis MR, Kalinowski FC
and Leedman PJ: miRNA-7-5p inhibits melanoma cell migration and
invasion. Biochem Biophys Res Commun. 430:706–710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giles KM, Brown RA, Ganda C, Podgorny MJ,
Candy PA, Wintle LC, Richardson KL, Kalinowski FC, Stuart LM, Epis
MR, et al: microRNA-7-5p inhibits melanoma cell proliferation and
metastasis by suppressing RelA/NF-κB. Oncotarget. 7:31663–31680.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi Y, Luo X, Li P, Tan J, Wang X, Xiang T
and Ren G: miR-7-5p suppresses cell proliferation and induces
apoptosis of breast cancer cells mainly by targeting REGγ. Cancer
Lett. 358:27–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shields JM, Christy RJ and Yang VW:
Identification and characterization of a gene encoding a gut
enriched Kruppel-like factor expressed during growth arrest. J Biol
Chem. 271:20009–20017. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kanai M, Wei D, Li Q, Jia Z, Ajani J, Le
X, Yao J and Xie K: Loss of Kruppel-like factor 4 expression
contributes to Sp1 overexpression and human gastric cancer
development and progression. Clin Cancer Res. 12:6395–6402. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei D, Kanai M, Jia Z, Le X and Xie K:
Kruppel-like factor 4 induces p27Kip1 expression in and suppresses
the growth and metastasis of human pancreatic cancer cells. Cancer
Res. 68:4631–4639. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lv H, Zhang Z, Wang Y, Li C, Gong W and
Wang X: MicroRNA-92a promotes colorectal cancer cell growth and
migration by inhibiting KLF4. Oncol Res. 23:283–290. 2016.
View Article : Google Scholar
|
|
19
|
Zhai F, Cao C, Zhang L and Zhang J:
miR-543 promotes colorectal cancer proliferation and metastasis by
targeting KLF4. Oncotarget. 8:59246–59256. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Edge SB, XXX BD, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Handbook. (7th).
2010.
|
|
23
|
Rowland BD and Peeper DS: KLF4, p21 and
context-dependent opposing forces in cancer. Nat Rev Cancer.
6:11–23. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu Q, Liu M, Zhang J, Xue L, Zhang G, Hu
C, Wang Z, He S, Chen L, Ma K, et al: Overexpression of KLF4
promotes cell senescence through microRNA-203-survivin-p21 pathway.
Oncotarget. 7:60290–60302. 2016.PubMed/NCBI
|
|
25
|
Zhang N, Zhang J, Shuai L, Zha L, He M,
Huang Z and Wang Z: Krüppel-like factor 4 negatively regulates
β-catenin expression and inhibits the proliferation, invasion and
metastasis of gastric cancer. Int J Oncol. 40:2038–2048.
2012.PubMed/NCBI
|
|
26
|
Hu W, Jia Y, Xiao X, Lv K, Chen Y, Wang L,
Luo X, Liu T, Li W, Li Y, et al: KLF4 downregulates hTERT
expression and telomerase activity to inhibit lung carcinoma
growth. Oncotarget. 7:52870–52887. 2016.PubMed/NCBI
|
|
27
|
Zhang W, Geiman DE, Shields JM, Dang DT,
Mahatan CS, Kaestner KH, Biggs JR, Kraft AS and Yang VW: The
gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates
the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J
Biol Chem. 275:18391–18398. 2000. View Article : Google Scholar : PubMed/NCBI
|
